med v tirzepatide Is Safe? Myths vs. Facts About This Weight Loss Medication – NM Aesthetics Wellness Tirzepatide Injection 20mg/ml 0.5mg 2ml

Appetite suppression becomes more noticeable, particularly around meal times

Evidence gaps Long-term (5+ year) outcomes data is still being collected

Working just as described

The new GIP receptor stimulus restarts metabolic pathways that had adapted to pure GLP-1 agonism

Injecting MOUNJARO Disposing of used needles and syringes Storing MOUNJARO Unopened vial: After vial has been opened: Keep MOUNJARO vials, syringes, needles, and all medicines out of the reach of children

The WHO estimates that more than 1 billion people worldwide are living with obesity, a condition that significantly increases the risk of cardiovascular disease, type 2 diabetes, cancer, and premature mortality